Josh Epstein is the founder and CEO of Stratevi and has over 16 years of work experience in HEOR and market access. He earned his PhD in Pharmaceutical Economics from the University of Southern California. Previously, Josh worked for 8 years at Baxalta Healthcare, most recently as Director of HEOR and Pricing for the Hematology Division. He has extensive experience in rare disease and gene therapies. He also has extensive experience developing HEOR strategy and deliverables to support product commercialization and launches across many disease areas.